Role of NF-κB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2

Blood

Volumn 93, Issue 9, 1999, Pages 3044-3052

  Feinman, Rena ^a,b   Koury, Jadd ^a   Thames, Michael ^a   Barlogie, Bart ^a   Epstein, Joshua ^a   Siegel, David S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; PROTEIN BCL 2; DNA; HYBRID PROTEIN; LUCIFERASE;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BONE MARROW; CELL CULTURE; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE;

APOPTOSIS; BONE MARROW; DEXAMETHASONE; DNA, NEOPLASM; GENES, BCL-2; GLUCOCORTICOIDS; HUMANS; LUCIFERASES; MULTIPLE MYELOMA; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033121314     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.3044     Document Type: Article

References (53)

1. Miguel-Garcia A, Orero T, Matutes E, Carbonell F, Miguel-Sosa A, Linares M, Tarin F, Herrera M, Garcia-Talavera J, Carbonell-Ramon F: bcl-2 expression in plasma cells from neoplastic gammopathies and reactive plasmacytosis: A comparative study. Hematologica 84:298, 1998
2. Pettersson M, Jernberg-Wiklund H, Larssin L-G, Sundstrom C, Givol I, Tsujimoto Y, Nilsson K: Expression of bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood 79:495, 1992
3. Reed JC: Double identity for proteins of the bcl-2 family. Nature 387:773, 1997
4. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614, 1997
5. Shibasaki F, Kondo E, Akagi T, McKeon F: Suppression of signaling through transcription factor NF-AT by interactions between calcineurin and bcl-2. Nature 386:728, 1997
6. Wang H-G, Rapp UR, Reed JC: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629, 1996
7. Fernandez-Sarabia MJ, Bischoff JR: Bcl-2 associates with the ras-related protein R-ras p23. Nature 266:274, 1993
8. Linette GP, Li Y, Roth K, Korsemeyer SJ: Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93:9545, 1996
9. Naumovski L, Cleary ML: The p53-binding protein 53BP2 also interacts with bcl-2 and impedes cell cycle progression at G2/M. Mol Cell Biol 16:3884, 1996
10. Mandal M, Maggirwar SB, Sharma N, Kaufmann SH, Sun S-C, Kumar R: Bcl-2 prevents CD95(Fas/APO-1)-induced degradation of lamin B and Poly(ADP-ribose)polymerase and restores the NF-κB signaling pathway. J Biol Chem 271:30354, 1996
11. Grimm S, Manuel KA, Bauer PA, Baeuerle PA, Schulze-Osthoff K: Bcl-2 downregulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol 134:13, 1996
12. Ivanov VI, Deng G, Podack ER, Malek TR: Pleiotropic effects of bcl-2 on transcription factors in T cells: Potential role of NF-κB p50-p50 for the anti-apoptotic function of bcl-2. Int Immunol 7:1709, 1995
13. Ivanov VN, Lee RK, Podack ER, Malek TR: Regulation of Fad-dependent activation-induced T cell apoptosis by cAMP signaling: A potential role for transcription factor NF-κB. Oncogene 14:2455, 1997
14. Lin K-I, Lee S-H, Narayanan R, Baraban JM, Hardwick JM: Thiol agents and bcl2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J Cell Biol 131:1149, 1995
15. Baeuerle PA, Baltimore D: NF-kappa B: Ten years after. Cell 87:13, 1996
16. Barnes PJ, Karin M: Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066, 1997
17. Whiteside ST, Israel A: IκB proteins: Structure, function and regulation. Semin Cancer Biol 8:75, 1997
18. DiDonato JA, Mercurio F, Karin M: Phosphorylation of IκB-α preceds but is not sufficient for its dissociation from NF-κB. Mol Cell Biol 15:1302, 1995
19. DiDonato J, Mercurio F, Rosette C, Wu-LI J, Suyang H, Ghosh S, Karin M: Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 16:1295, 1996
20. Mailinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540, 1997
21. DiDonato J, Hayakama M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive IκB kinas that activates the transcription factor NF-κB. Nature 388:548, 1997
22. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li JW, Young DB, Barbosa M, Mann M, Manning A, Rao A: IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860, 1997
23. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M: Identification and characterization of a IκB kinase. Cell 90:373, 1997
24. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS: Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 15:943, 1995
25. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286, 1995
26. Hardin J, Macleod S, Grigorieve I, Chang R, Barlogie B, Xiao H, Epstein J: Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063, 1994
27. Schreiber EB, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
28. Fried M, Crothers DM: Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6506, 1981
29. Zhang YH, Lin JX, Vilcek J: Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol 10:3818, 1990
30. Hata H, Xiao H, Petrucci M, Woodliff J, Chang R, Epstein J: Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood 81:3357, 1993
31. Yang E, Korsemeyer SJ: Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 88:386, 1996
32. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr: Role of transcnptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283, 1995
33. Miyamoto S, Chiao P, Verma IM: Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B cell lines. Mol Cell Biol 14:3276, 1994
34. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B: Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100:2961, 1997
35. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr: Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629, 1997
36. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE: Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100:2952, 1997
37. Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino F, Curcio F, Santoro M, Fusco A: Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression. Oncogene 15:1987, 1997
38. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782, 1996
39. Wang C-Y, Mayo MW, Baldwin AS Jr: TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784, 1996
40. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787, 1996
41. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MJ, Rothstein TL, Sherr DH, Sonenshein GE: Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 15:4682, 1996
42. Ravi R, Bedi A, Fuchs EJ, Bedi A: CD95 (fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res 58:882, 1998
43. Herrmann JL, Behan AW, Sarkiss M, Chiao PJ, Rands MT, Bruckheimer EM, Brisbay S, McDonnell TJ: Bcl-2 suppresses apoptosis resulting from disruption of the NF-κB survival pathway. Exp Cell Res 237:101, 1997
44. Helmberg A, Auphan N, Caelles C, Karin M: Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14:452, 1995
45. De Bosscher K, Schmitz ML, Berghe WV, Plaisance S, Fiers W, Haegeman G: Glucocorticoid-mediated repression of nuclear factor-κB dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 94:13504, 1997
46. Wissink S, van Heerde EC, Schmitz ML, Kalkhoven E, van der Burg B, Baeuerle PA, van der Saag PT: Distinct domains of the RelA NF-κB subunit are required for negative crosstalk and direct interaction with the glucocorticoid receptor. J Biol Chem 272:22278, 1997
47. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato ACB: IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor. J Biol Chem 16:4698, 1997
48. Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer H-D, Scheidereit C, Dorken B: High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87:4340, 1996
49. Wood KM, Roff M, Hay RT: Defective IκBα in Hodgkin cell lines with constitutively active NF-κB. Oncogene 16:2131, 1998
50. Suyang H, Phillips I, Douglas I, Ghosh S: Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol Cell Biol 16:5444, 1996
51. McKinsey TA, Chu Z-L, Ballard DW: Phosphorylation of the PEST domain of IκBβ regulates the function of NF-κB/IκBβ complexes. J Biol Chem 272:22377, 1997
52. Whiteside ST, Epinat JC, Rice NR, Israel A: I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16:1413, 1997
53. Li Z, Nabel GJ: A new member of the IκB protein family, IκB∈, inhibited RelA (p65)-mediated NF-κB transcription. Mol Cell Biol 17:6184, 1997